GCC Comprehensive Nursing Reference — Clinical Practice Guide
GCC Edition 2026 | For Registered Nurses| BMI (kg/m²) | Classification | Health Risk | GCC Prevalence Context |
|---|---|---|---|
| < 18.5 | Underweight | Increased (nutritional) | Low in GCC adult population |
| 18.5 – 24.9 | Normal Weight | Average | Decreasing proportion in GCC |
| 25.0 – 29.9 | Overweight | Mildly increased | ~25–30% GCC adults |
| 30.0 – 34.9 | Class I Obesity | Moderately increased | Significant GCC burden |
| 35.0 – 39.9 | Class II Obesity | Severely increased | High in Gulf states |
| ≥ 40.0 | Class III / Morbid Obesity | Very severely increased | Kuwait rates highest regionally |
| Measurement | Risk Level |
|---|---|
| < 80 cm | Low |
| 80 – 88 cm | Increased |
| > 88 cm | Substantially Increased |
| Measurement | Risk Level |
|---|---|
| < 94 cm | Low |
| 94 – 102 cm | Increased |
| > 102 cm | Substantially Increased |
EOSS is a 5-stage system that captures the clinical impact of obesity beyond BMI alone. It guides treatment intensity decisions.
Diagnosis requires ≥3 of the following 5 criteria:
| Criterion | Threshold | Notes |
|---|---|---|
| Waist circumference | Men ≥94 cm / Women ≥80 cm (European/GCC) | Use population-specific cut-offs |
| Fasting triglycerides | ≥ 1.7 mmol/L (150 mg/dL) | Or on fibrate/nicotinic acid treatment |
| HDL-cholesterol | Men <1.0 mmol/L / Women <1.3 mmol/L | Or on HDL-raising treatment |
| Blood pressure | Systolic ≥130 or Diastolic ≥85 mmHg | Or on antihypertensive treatment |
| Fasting glucose | ≥ 5.6 mmol/L (100 mg/dL) | Or on antidiabetic treatment |
Psychosocial assessment is mandatory pre-bariatric surgery. Identify conditions that may impact surgical outcomes or require pre-operative treatment.
| Domain | Key Screening Questions / Tools | Action if Identified |
|---|---|---|
| Binge Eating Disorder | Binge Eating Scale (BES); loss-of-control episodes ≥2×/week for 6 months | CBT pre-operatively; surgery not contraindicated but outcomes worse if untreated |
| Depression | PHQ-9; assess current medications, suicidal ideation history | Antidepressant optimisation; post-op absorption changes require monitoring |
| Anxiety | GAD-7; health anxiety, surgical anxiety | Psychological support; patient education reduces procedural anxiety |
| PTSD / Trauma | Trauma history; adverse childhood experiences | Trauma-informed care approach; may delay surgery |
| Substance Use | AUDIT (alcohol); illicit drug use; transfer addiction risk post-surgery | Sobriety requirement (typically 12 months); addiction support services |
| Eating Behaviours | Night eating syndrome, emotional eating, grazing patterns | Behavioural change programmes; follow-up dietitian sessions |
Purpose of pre-operative VLCD:
VLCD Protocol:
| Nutrient | Test | Significance |
|---|---|---|
| Iron / Ferritin | Serum iron, TIBC, ferritin | Deficiency common pre-op; risk worsens post bypass |
| Vitamin B12 | Serum B12 | Deficiency risk increases dramatically after gastric bypass |
| Folate | Serum / RBC folate | Critical in women of reproductive age |
| Vitamin D | 25-OH Vitamin D | High deficiency prevalence in GCC despite sun exposure (cultural dress/indoor lifestyle) |
| Calcium | Serum calcium, PTH if D low | Post-bypass calcium malabsorption risk |
| Thiamine (B1) | Serum thiamine / erythrocyte transketolase | Risk of Wernicke's encephalopathy if vomiting post-op |
| Zinc | Serum zinc | Hair loss post-bypass partly related to zinc deficiency |
| HbA1c | Glycated haemoglobin | Glycaemic optimisation pre-op reduces wound infection risk |
| LFTs / Albumin | Liver function, albumin | Hepatic steatosis severity; nutritional reserve |
STOP-BANG Screening Score
Pre-operative CPAP Optimisation
| Weight | Enoxaparin Dose (Example Protocol) | Timing |
|---|---|---|
| < 100 kg | Enoxaparin 40 mg SC once daily | Pre-op + continue ≥28 days post-op |
| 100 – 150 kg | Enoxaparin 40 mg SC twice daily | Extended prophylaxis recommended |
| > 150 kg | Anti-Xa level guided dosing (target 0.2–0.4 IU/mL) | Consult haematology; monitor anti-Xa 4h post dose |
| Procedure | Mechanism | Expected Excess Weight Loss | Key Nursing Consideration |
|---|---|---|---|
| Sleeve Gastrectomy (SG) | Restrictive. 75–80% of stomach removed (greater curvature). Ghrelin reduction. | 55–70% EWL at 2 years | GORD may worsen; staple line bleeding risk; no anastomosis |
| Roux-en-Y Gastric Bypass (RYGB) | Restrictive + malabsorptive. Small gastric pouch + bypassed limb of small intestine. | 65–80% EWL at 2 years | Anastomotic leak risk; dumping syndrome; significant nutritional supplementation lifelong |
| Adjustable Gastric Band (AGB) | Purely restrictive. Inflatable band around upper stomach. Least invasive. | 40–55% EWL at 2 years | Band slippage / erosion / port complications; band adjustments (fills) required |
| Biliopancreatic Diversion + Duodenal Switch (BPD/DS) | Primarily malabsorptive. Sleeve gastrectomy + long bypass limb. Most effective for T2DM. | 70–80% EWL; highest T2DM remission | Greatest nutritional deficiency risk; complex surgery; reserved for BMI >50 or metabolic goals |
| Mini Gastric Bypass (MGB / OAGB) | One anastomosis; loop gastroenterostomy. Growing in GCC. | 60–75% EWL | Bile reflux risk; simpler than RYGB; increasing adoption in Gulf centres |
Positioning Protocol
Why Ramped Position Matters
| Equipment | Specification / Standard | Nursing Action |
|---|---|---|
| Bariatric Bed | Weight capacity ≥250–300 kg (standard beds 130–150 kg). Wide frame models (≥900mm). | Confirm weight capacity before patient transfer. Order in advance from equipment pool. |
| Hover Mattress / Air Transfer Systems | Inflatable lateral transfer aid (e.g., HoverMatt). Reduces manual handling injury. | Use for all bed-to-trolley transfers. Reduces friction shear injury. |
| Wide/Large BP Cuff | Bladder width = 40% arm circumference; length = 80%. Bariatric cuffs 42–50 cm. | Measure mid-arm circumference. Inaccurate small cuffs give falsely elevated readings. |
| Reinforced Operating Trolley/Table | Bariatric operating table capacity ≥300 kg. Wide tabletop extensions. | Confirm table capacity with theatre team. Ensure side extensions fitted and locked. |
| Bariatric Compression Stockings | Thigh-high, measured and fitted to correct size (thigh/calf/foot circumference). | Measure and document; reorder correct size. Ill-fitting stockings increase tourniquet risk. |
| Bariatric Wheelchair/Shower Chair | Capacity ≥250 kg; wider seat ≥600 mm. | Assess need pre-operatively; order before admission date. |
| Ceiling Hoist / Mobile Hoist | Weight-rated hoists with bariatric sling fitting. | Manual handling risk assessment mandatory. Use hoist for all dependent transfers. |
| Priority | Intervention | Rationale |
|---|---|---|
| Airway | Extubate in ramped/reverse Trendelenburg position. SpO₂ monitoring continuous. CPAP restart immediately on arrival. | Post-extubation upper airway obstruction risk. FRC decreases rapidly supine. |
| Oxygenation | Target SpO₂ ≥94%. Supplemental O₂ initially. Titrate to patient baseline. | Hypoventilation and atelectasis common post-bariatric surgery. |
| Pain Management | Multimodal analgesia — avoid high-dose opioids. Paracetamol IV, NSAIDs (if no contraindication), local anaesthetic port site infiltration, TAP block. | Opioids worsen OSA, respiratory depression; multimodal reduces total opioid requirement. |
| Positioning | Head of bed elevated ≥30–45°. Avoid supine in OSA patients. | Reduces aspiration risk, improves ventilation, reduces oedema. |
| Nausea/Vomiting | Prophylactic antiemetics (ondansetron + dexamethasone dual therapy). PONV risk HIGH. | Vomiting causes staple line stress. PONV predicts prolonged hospital stay. |
| VTE Prevention | LMWH first dose (if no bleeding), foot pumps active, early mobilisation within hours. | VTE risk highest 3–7 days post-surgery but begins immediately. |
| Drain / Wound | Document drain output colour and volume. Bloody drain output → escalate. Inspect wound for haematoma. | Staple line haemorrhage typically apparent in first 2–4 hours. |
| Fluid Balance | IV maintenance at 125–150 mL/hr initially. Monitor UO ≥0.5 mL/kg/hr (use IBW). Avoid overhydration. | Bariatric patients prone to pulmonary oedema with excess IV fluid. |
Clinical Features (Finsterer Criteria Adapted)
Investigation & Management
| Feature | Details |
|---|---|
| Timing | Usually within first 24–48 hours post-op |
| Incidence | 1–4% of bariatric procedures |
| Signs | Haematemesis, melaena, haematochezia, tachycardia, hypotension, falling Hb on bloods |
| Intraluminal vs Extraluminal | Intraluminal: presents with bloody NGT aspirate or haematochezia. Extraluminal: haemoperitoneum, drain bloody output. |
| Management | Haemodynamic resuscitation. Intraluminal: endoscopy + haemostatic clipping. Extraluminal: CT angiography vs. return to theatre. |
| Prevention | Buttressing staple lines, staplers sized to tissue thickness, oversewing, fibrin glue at surgeon discretion |
Clinical Features
Investigations & Management
| Early Dumping | Late Dumping | |
|---|---|---|
| Timing | 15–30 minutes post-meal | 1–3 hours post-meal |
| Mechanism | Rapid transit of hyperosmolar chyme into small bowel → fluid shift → bowel distension + gut hormone release (GLP-1, PYY, neurotensin) | Reactive hypoglycaemia — exaggerated insulin response to rapid carbohydrate absorption |
| Symptoms | Vasomotor: flushing, palpitations, sweating, nausea, vomiting, bloating, diarrhoea, dizziness | Hypoglycaemia: tremor, sweating, confusion, hunger, palpitations, syncope |
| Diagnosis | Clinical history. Provocative glucose meal test. | OGTT showing reactive hypoglycaemia <3.0 mmol/L. Mixed meal tolerance test. |
| Management | Dietary: small meals, low simple carbs, high protein, separate fluids from meals. Acarbose (reduces carb absorption). Octreotide in refractory cases. | Low glycaemic index diet. Avoid sugary foods/drinks. Acarbose. Rarely: surgery (reversal) for refractory hypoglycaemia. |
| Procedure risk | Roux-en-Y gastric bypass highest risk. Also mini bypass, sleeve less commonly. | RYGB. Rare but dangerous — can present as neuroglycopaenia. |
Post-Bariatric Complication Assessment Tool
| Nutrient | Risk Procedure | Mechanism of Deficiency | Clinical Features | Monitoring |
|---|---|---|---|---|
| Iron | RYGB, BPD/DS | Bypassed duodenum (primary absorption site); reduced gastric acid for ferric→ferrous conversion | Fatigue, pallor, koilonychia, pica, hair loss | Ferritin + serum iron + TIBC at 6, 12, 24 months |
| Vitamin B12 | RYGB, SG | Reduced intrinsic factor (parietal cell reduction); reduced gastric acid | Macrocytic anaemia, subacute combined degeneration of cord, peripheral neuropathy, glossitis | Serum B12 annually; sublingual or IM preferred routes post-bypass |
| Folate | RYGB, BPD/DS | Bypassed jejunum; reduced intake | Macrocytic anaemia; NTDs in pregnancy — CRITICAL in fertile women | RBC folate annually; 5 mg/day pre-conception |
| Calcium | RYGB, BPD/DS | Bypassed duodenum/jejunum; requires acid for absorption; low Vitamin D compounds risk | Tetany, perioral paraesthesia, osteoporosis, bone pain | Serum calcium, PTH, Vitamin D annually. DEXA at 2 years. |
| Vitamin D | All procedures (esp. RYGB, BPD) | Fat-soluble; malabsorption; reduced dietary intake; already endemic deficiency in GCC | Muscle weakness, bone pain, secondary hyperparathyroidism | 25-OH Vitamin D annually. Target >75 nmol/L post-bariatric. |
| Thiamine (B1) | All (esp. RYGB) | Reduced intake; persistent vomiting; depleted rapidly (no body stores) | Wernicke's encephalopathy (ophthalmoplegia, ataxia, confusion), Korsakoff syndrome, peripheral neuropathy | Serum thiamine if vomiting; supplement ALL patients with persistent vomiting IV BEFORE giving dextrose |
| Zinc | RYGB, BPD/DS, SG | Reduced meat intake; reduced absorption; phytate competition | Hair loss (telogen effluvium), poor wound healing, taste change, immune dysfunction | Serum zinc annually |
| Magnesium | BPD/DS, RYGB | Malabsorption; losses | Muscle cramps, cardiac arrhythmias, tetany, fatigue | Serum magnesium annually |
| Vitamin A | BPD/DS | Fat-soluble; severe malabsorption | Night blindness, dry eyes, immune dysfunction | Retinol level annually in BPD/DS patients |
| Supplement | Standard Dose | Route | Notes |
|---|---|---|---|
| A-Z Bariatric Multivitamin | Once or twice daily (product-dependent) | Oral (chewable initially) | Must be bariatric-specific formulation with adequate micronutrient doses. Start first week post-op. |
| Calcium Citrate | 1200–1500 mg/day (in divided doses) | Oral | Citrate NOT carbonate — carbonate requires gastric acid for absorption which is reduced post-bypass. Take with food. Maximum 500 mg per dose. |
| Vitamin D3 | 3000–6000 IU/day (dose-adjust to blood level) | Oral | Often combined with calcium. Target 25-OH VitD >75 nmol/L. Higher doses may be needed in BPD/DS. |
| Vitamin B12 | 1 mg/day sublingual OR 1 mg IM monthly | Sublingual / IM injection | Oral cyanocobalamin poorly absorbed post-RYGB due to intrinsic factor reduction. IM route most reliable. |
| Iron | 45–60 mg elemental iron/day (menstruating women: 45–60 mg twice daily) | Oral (take with Vitamin C) | Ferrous sulphate (cheapest), fumarate, or gluconate. Take on empty stomach or with Vitamin C to improve absorption. Separate from calcium by 2 hours. |
| Folate | 400–800 mcg/day standard; 5 mg/day if planning pregnancy | Oral | Critical in women of reproductive age. Included in most bariatric multivitamins. |
| Thiamine (B1) | 50–100 mg/day prophylactic | Oral | IV thiamine 100–200 mg immediately if persistent vomiting BEFORE any IV dextrose is given. |
| Zinc | 8–11 mg/day (higher in BPD/DS: 16–22 mg) | Oral | Usually included in bariatric multivitamin. Separate from iron and calcium by 2 hours. |
Water, diluted juice, clear broth. Sip slowly — no gulping. 30 mL per 15 minutes initially.
Protein shakes, yogurt, puréed soups, smooth mashed potato. No lumps. Focus on protein.
Soft cooked fish, scrambled eggs, minced meat, soft vegetables. Chew thoroughly. Tiny portions.
Expanding variety. Continue avoiding tough meats, bread, raw vegetables, carbonated drinks.
Balanced diet. Small meals. Avoid drinking with meals lifelong. Continue avoiding high-sugar foods.
Dietary Rules for Dumping Prevention
Trigger Foods to Avoid
| Timepoint | Clinical Review | Blood Tests | Additional |
|---|---|---|---|
| 2 weeks | Wound check, dietary tolerance, fluid intake, protein intake | FBC, UE, LFTs, glucose | Staple line integrity if concerns. Remove sutures. |
| 6 weeks | Weight, dietary stage progression, physical activity, medications review | FBC, iron, B12, folate, calcium, vitamin D, HbA1c | Diabetes medications adjustment. CPAP reassessment. |
| 3 months | Weight loss progress, dietary compliance, psychological wellbeing | Full nutritional bloods (as above + thiamine, zinc) | Dietitian review. Consider stopping antihypertensives if BP normalised. |
| 6 months | Comprehensive review — weight, comorbidities, QoL, dumping symptoms | Full nutritional panel + lipid profile + thyroid | Endoscopy if symptoms. Band fill if AGB. Psychologist if needed. |
| 12 months | Annual review — target ≥50% EWL by 12 months RYGB/SG | Full nutritional panel + HbA1c + lipids + PTH | Discuss fertility, contraception, body contouring surgery referral |
| 24 months | Long-term weight maintenance strategies, vigilance for weight regain | Full nutritional panel + DEXA scan | DEXA bone densitometry. Assess for metabolic disease remission. |
| Annual (lifelong) | Weight trends, adherence to supplements, any new symptoms | Minimum: FBC, iron, B12, folate, calcium, VitD, HbA1c | Reinforce lifelong supplementation. Screen for depression, transfer addiction. |
| Cultural Factor | Impact on Obesity | Nursing Approach |
|---|---|---|
| Sedentary Indoor Lifestyle | Extreme heat (40–50°C summers) prevents outdoor physical activity for much of the year. Air-conditioned indoor sedentary life. | Promote indoor physical activity options (malls, gyms, home exercise). Set realistic seasonal expectations. |
| Car Culture | Very low walking rates. Drive-throughs, valet parking, minimal pedestrian infrastructure. Car dependency from childhood. | Encourage walking within buildings, parking farther away. Discuss brief activity bursts. |
| Social Eating Occasions | Generous hospitality culture. Refusing food considered impolite. Large family gatherings with abundant high-calorie food. | Portion control strategies. Permission to politely decline seconds. Healthier cooking substitutions. |
| Ramadan Binge-Restrict Cycle | Daytime fasting followed by high-calorie iftar and suhoor meals. Disrupted sleep. Weight often gained during Ramadan despite fasting. | Ramadan-specific dietary counselling. Balanced iftar meals. Maintain physical activity during Ramadan evenings. |
| Dietary Transition | Shift from traditional Bedouin diet (dates, fish, camel products) to ultra-processed Western fast food. High sugar-sweetened beverage consumption. | Culturally informed nutrition education. Return to traditional healthier foods where appropriate. |
| Female Activity Restrictions | Cultural and dress norms limit physical activity for women in some GCC countries, though rapidly changing. Women's obesity rates equal or exceed men's. | Women-only gym facilities. Home exercise programmes. Respect cultural norms whilst promoting activity. |
| Child Feeding Practices | Overfeeding of children associated with prosperity/care. Early introduction of high-sugar foods. Childhood obesity rates very high. | Family-centred obesity prevention. Parent education. Culturally sensitive reframing of "healthy child." |
| Drug Category | Effect Post-Surgery | Nursing Action |
|---|---|---|
| Antidiabetics (Metformin) | Absorption may decrease (bypassed absorption site) but glycaemic control often dramatically improves. High hypoglycaemia risk. | Monitor glucose closely. Dose reduction or cessation likely. Avoid sulfonylureas post-op (hypoglycaemia risk). Switch to liquid/dispersible metformin. |
| Antihypertensives | BP often normalises as weight falls. Antihypertensives may cause symptomatic hypotension. | Daily BP monitoring. Dose reduction or cessation may be needed within days to weeks of surgery. |
| Antidepressants (SSRIs) | RYGB may increase peak serum concentrations due to altered absorption kinetics (rapid small bowel delivery). SSRIs may increase marginal ulcer risk (RYGB). | Monitor for side effects; consider dose review. Some patients need dose increase as weight loss reduces volume of distribution. |
| Oral Contraceptives | Absorption may be unpredictable post-bypass. Risk of unintended pregnancy — fertility rapidly restored post-surgery. | Switch to non-oral contraception (implant, IUD, injectable) for at least 12–24 months post-surgery. Counsel on fertility restoration. |
| Immunosuppressants (transplant patients) | Unpredictable absorption — serious risk of rejection. Bariatric surgery in transplant patients is high-risk. | Specialist centre only. Frequent drug level monitoring. Close liaison between bariatric and transplant teams. |
| Modified-release / Enteric-coated tablets | Modified-release formulations may not work correctly — drug released too fast or in wrong segment. | Convert to immediate-release or liquid formulations. Crush only if safe (check BNF / MIMS). Avoid crushing enteric-coated preparations. |
| NSAIDs | CONTRAINDICATED post-RYGB and BPD/DS — marginal ulcer risk. High-risk even post-sleeve. | Lifelong avoidance. Paracetamol (liquid or dispersible) as first-line analgesic. |
| Alcohol | Rapid absorption post-RYGB — peak BAC higher and faster. Significant transfer addiction risk. | Educate on increased sensitivity. Advise avoidance particularly in first year. Screen for alcohol use at follow-up. |
Fertility Restoration Mechanisms
Pregnancy After Bariatric Surgery
| Time Since Surgery | Ramadan Fasting Guidance | Clinical Considerations |
|---|---|---|
| < 12 months | NOT RECOMMENDED — exemption from fasting justified medically and by Islamic scholar guidance (marad exemption) | High nutritional risk during rapid weight loss phase. Dehydration risk. Supplement compliance difficult. Haematological complications. |
| 12–24 months | CAUTION — individual assessment required with bariatric team + Islamic scholar opinion | Monitor hydration closely during iftar-suhoor window. Optimise supplement intake at suhoor. Blood glucose monitoring if diabetic. |
| > 24 months, weight stable | MAY BE POSSIBLE with medical supervision and adapted eating plan | Balanced high-protein iftar and suhoor. Avoid refined carbohydrates post-fast. Continue all supplements. Avoid dehydration. |
| Bariatric Surgery | جراحة السمنة (Jirahat al-Sumna) |
| Obesity | السمنة (Al-Sumna) |
| Weight loss | إنقاص الوزن (Inqas al-Wazn) |
| Gastric sleeve | تكميم المعدة (Takmeeh al-Mida) |
| Gastric bypass | تحويل مسار المعدة (Tahweel Masar al-Mida) |
| Nutritional supplement | مكمل غذائي (Mukammil Ghazaee) |
| Protein | البروتين (Al-Broteen) |
| Follow-up appointment | موعد المتابعة (Maw'id al-Mutaba'a) |
Pattern Description
Nursing Management